Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma
X Zhu, T Sun, H Lu, X Zhou, Y Lu, X Cai… - Journal of clinical …, 2010 - jcp.bmj.com
Aims To evaluate CK19, RET, galectin-3 and HBME-1 expression in papillary thyroid
carcinoma (PTC) and to evaluate their diagnostic significance. Methods 155 PTC specimens …
carcinoma (PTC) and to evaluate their diagnostic significance. Methods 155 PTC specimens …
[HTML][HTML] Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy
HA Saleh, J Feng, F Tabassum, O Al-Zohaili… - Cytojournal, 2009 - ncbi.nlm.nih.gov
Background: Fine needle aspiration biopsy (FNAB) is a common and excellent procedure for
the evaluation of thyroid lesions that require surgical resection. At times, the FNAB diagnosis …
the evaluation of thyroid lesions that require surgical resection. At times, the FNAB diagnosis …
[HTML][HTML] Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China
Q Song, D Wang, Y Lou, C Li, C Fang, X He, J Li - Diagnostic pathology, 2011 - Springer
Background To evaluate the expression and differential diagnostic significance of CK19, TG,
Ki67 and galectin-3 in papillary thyroid carcinoma (PTC)(metastatic and non metastatic) …
Ki67 and galectin-3 in papillary thyroid carcinoma (PTC)(metastatic and non metastatic) …
The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination
H Ma, S Xu, J Yan, C Zhang, S Qin, X Wang… - Polish Journal of …, 2014 - termedia.pl
Aim of the study is to evaluate the expression of CK19, galectin-3, HBME-1, CD56, claudin-1
and neutrophil gelatinase-associated lipocalin (NGAL) in papillary thyroid carcinoma (PTC) …
and neutrophil gelatinase-associated lipocalin (NGAL) in papillary thyroid carcinoma (PTC) …
Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an …
JE Barroeta, ZW Baloch, P Lal, TL Pasha, PJ Zhang… - Endocrine …, 2006 - Springer
Background Several immunohistochemical markers have been used to aid in the diagnosis
of follicular-derived lesions of the thyroid (FDLT). In this study we analyze the diagnostic …
of follicular-derived lesions of the thyroid (FDLT). In this study we analyze the diagnostic …
Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?
G Wu, J Wang, Z Zhou, T Li… - Journal of international …, 2013 - journals.sagepub.com
Objectives To investigate the ability of cytokeratin (CK)-19, galectin-3, human bone marrow
endothelial cell (HBME)-1 and tyrosine kinase-type cell surface receptor HER2 (HER-2/neu) …
endothelial cell (HBME)-1 and tyrosine kinase-type cell surface receptor HER2 (HER-2/neu) …
[HTML][HTML] Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma
Z Liu, P Yu, Y Xiong, W Zeng, X Li… - … Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Objectives: To evaluate the expression and significance of CK19, TPO, and HBME-1 in the
differential diagnosis of papillary thyroid carcinoma (PTC) and nonmalignant nodules …
differential diagnosis of papillary thyroid carcinoma (PTC) and nonmalignant nodules …
Simultaneous immunohistochemical expression of HBME‐1 and galectin‐3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid
ED Rossi, M Raffaelli, A Mule', A Miraglia… - …, 2006 - Wiley Online Library
Aims: The histological diagnosis is critical for the postsurgical management and follow‐up of
thyroid malignancies. The differential diagnosis between papillary carcinoma and …
thyroid malignancies. The differential diagnosis between papillary carcinoma and …
Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19
AR Murtezaoglu, H Gucer - Polish Journal of Pathology, 2017 - termedia.pl
Respectively 73.8%, 83.3%, 69% and 50% of all papillary carcinomas were positive with
HBME-1, CK19, galectin-3 and TROP-2. CK19 was positive respectively by 100%, 43.5 …
HBME-1, CK19, galectin-3 and TROP-2. CK19 was positive respectively by 100%, 43.5 …
[HTML][HTML] Diagnostic accuracy of CK-19, Galectin-3 and HBME-1 on papillary thyroid carcinoma: a meta-analysis
Y Xin, D Guan, K Meng, Z Lv, B Chen - International journal of …, 2017 - ncbi.nlm.nih.gov
The study aimed at evaluating the diagnostic accuracy of cytokeratin 19 (CK-19), Galectin-3
and hector battifora mesothelial antigen-1 (HBME-1) for papillary thyroid carcinoma (PTC) …
and hector battifora mesothelial antigen-1 (HBME-1) for papillary thyroid carcinoma (PTC) …
相关搜索
- hbme 1 galectin 3
- hbme 1 thyroid carcinoma
- thyroid carcinoma galectin 3
- diagnostic significance galectin 3
- diagnostic significance thyroid carcinoma
- differential expression galectin 3
- hbme 1 differential expression
- ret oncoprotein galectin 3
- hbme 1 diagnostic value
- ret oncoprotein differential expression
- lesions of the thyroid differential expression
- thyroid carcinoma immunohistochemical markers
- diagnostic value differential expression
- papillary carcinomas hyperfunctioning lesions
- hbme 1 hyperfunctioning lesions
- ret oncoprotein thyroid neoplasms